Molina Healthcare (MOH) Projected to Announce Earnings on Wednesday

Molina Healthcare (NYSE:MOH) is anticipated to issue its Q2 2026 results after the market closes on Wednesday, July 22nd. Analysts expect Molina Healthcare to announce earnings of $1.37 per share and revenue of $10.8225 billion for the quarter. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. Investors are encouraged to explore the company’s upcoming Q2 2026 earning overview page for the latest details on the call scheduled for Thursday, July 23, 2026 at 8:00 AM ET.

Molina Healthcare (NYSE:MOH) last posted its quarterly earnings data on Wednesday, April 22nd. The company reported $2.35 EPS for the quarter, topping analysts’ consensus estimates of $1.57 by $0.78. Molina Healthcare had a return on equity of 8.76% and a net margin of 0.42%.The company had revenue of $10.80 billion for the quarter, compared to analyst estimates of $10.91 billion. During the same period in the previous year, the firm earned $6.08 earnings per share. The firm’s quarterly revenue was down 3.1% on a year-over-year basis. On average, analysts expect Molina Healthcare to post $5 EPS for the current fiscal year and $9 EPS for the next fiscal year.

Molina Healthcare Stock Performance

Shares of MOH stock opened at $241.30 on Wednesday. The stock has a market capitalization of $12.57 billion, a PE ratio of 71.39 and a beta of 0.74. The business’s 50 day simple moving average is $201.25 and its 200 day simple moving average is $174.25. The company has a debt-to-equity ratio of 0.97, a current ratio of 1.63 and a quick ratio of 1.63. Molina Healthcare has a one year low of $121.06 and a one year high of $244.89.

Wall Street Analyst Weigh In

MOH has been the topic of a number of analyst reports. Bank of America raised shares of Molina Healthcare from an “underperform” rating to a “buy” rating and set a $250.00 price objective on the stock in a research note on Wednesday, April 29th. Zacks Research raised shares of Molina Healthcare from a “strong sell” rating to a “hold” rating in a research note on Monday, April 20th. Truist Financial boosted their target price on shares of Molina Healthcare from $205.00 to $250.00 and gave the company a “hold” rating in a report on Tuesday. Wells Fargo & Company upped their price target on shares of Molina Healthcare from $159.00 to $235.00 and gave the company an “equal weight” rating in a research report on Monday. Finally, Barclays decreased their price target on Molina Healthcare from $199.00 to $184.00 and set an “underweight” rating for the company in a report on Wednesday, July 8th. Three research analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $207.06.

Insider Transactions at Molina Healthcare

In related news, CAO Maurice Hebert sold 600 shares of the stock in a transaction on Thursday, May 14th. The stock was sold at an average price of $191.55, for a total value of $114,930.00. Following the completion of the sale, the chief accounting officer directly owned 12,815 shares of the company’s stock, valued at approximately $2,454,713.25. This represents a 4.47% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Jeff D. Barlow sold 17,811 shares of the stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $186.12, for a total transaction of $3,314,983.32. Following the completion of the sale, the insider owned 67,175 shares of the company’s stock, valued at approximately $12,502,611. This represents a 20.96% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 1.44% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the stock. Baird Financial Group Inc. purchased a new position in Molina Healthcare during the first quarter worth about $210,000. NewEdge Advisors LLC lifted its position in Molina Healthcare by 33.4% during the first quarter. NewEdge Advisors LLC now owns 1,106 shares of the company’s stock valued at $364,000 after purchasing an additional 277 shares during the last quarter. Jones Financial Companies Lllp grew its stake in Molina Healthcare by 713.3% in the 1st quarter. Jones Financial Companies Lllp now owns 1,651 shares of the company’s stock worth $544,000 after buying an additional 1,448 shares in the last quarter. Goldman Sachs Group Inc. grew its stake in Molina Healthcare by 19.4% in the 1st quarter. Goldman Sachs Group Inc. now owns 249,466 shares of the company’s stock worth $82,172,000 after buying an additional 40,531 shares in the last quarter. Finally, Woodline Partners LP bought a new position in shares of Molina Healthcare in the 1st quarter worth $1,541,000. 98.50% of the stock is owned by institutional investors.

Molina Healthcare Company Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.